Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Preatoni

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Recenti Progressi in Medicina|May 1, 1991
[The interleukin-2 receptor]P Marino, A Preatoni
Cancer|August 15, 1995
Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysisP Marino, A Preatoni, A Cantoni
Lung Cancer (Amsterdam, Netherlands)|August 1, 1995
Single-agent chemotherapy versus combination chemotherapy in advanced non-small cell lung cancer: a quality and meta-analysis studyP Marino, A Preatoni, A Cantoni, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Increased levels of soluble interleukin-2 receptors in supernatants from peripheral blood mononuclear cells of patients with lung cancerP Marino, A Preatoni, G Buccheri, et al.
Chest|September 1, 1994
Chemotherapy vs supportive care in advanced non-small-cell lung cancer. Results of a meta-analysis of the literatureP Marino, S Pampallona, A Preatoni, et al.
Liver|February 1, 1996
Liver abscesses due to Listeria monocytogenesP Marino, M Maggioni, A Preatoni, et al.
Chest|June 1, 1991
Soluble interleukin 2 receptor in lung cancer. An indirect marker of tumor activity?G Buccheri, P Marino, A Preatoni, et al.
Recenti Progressi in Medicina|November 1, 1990
Biomarkers and IL-2R in lung cancerP Marino, A Preatoni, L Fonticoli, et al.
The International Journal of Biological Markers|January 1, 1992
Tissue polypeptide specific antigen (TPS) and objective response to treatment in solid tumorsP Marino, G Buccheri, A Preatoni, et al.
British Journal of Cancer|March 1, 1990
Increased levels of soluble interleukin-2 receptors in serum of patients with lung cancerP Marino, M Cugno, A Preatoni, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Recenti Progressi in Medicina|May 1, 1991
[The interleukin-2 receptor]P Marino, A Preatoni
Cancer|August 15, 1995
Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysisP Marino, A Preatoni, A Cantoni
Lung Cancer (Amsterdam, Netherlands)|August 1, 1995
Single-agent chemotherapy versus combination chemotherapy in advanced non-small cell lung cancer: a quality and meta-analysis studyP Marino, A Preatoni, A Cantoni, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Increased levels of soluble interleukin-2 receptors in supernatants from peripheral blood mononuclear cells of patients with lung cancerP Marino, A Preatoni, G Buccheri, et al.
Chest|September 1, 1994
Chemotherapy vs supportive care in advanced non-small-cell lung cancer. Results of a meta-analysis of the literatureP Marino, S Pampallona, A Preatoni, et al.
Liver|February 1, 1996
Liver abscesses due to Listeria monocytogenesP Marino, M Maggioni, A Preatoni, et al.
Chest|June 1, 1991
Soluble interleukin 2 receptor in lung cancer. An indirect marker of tumor activity?G Buccheri, P Marino, A Preatoni, et al.
Recenti Progressi in Medicina|November 1, 1990
Biomarkers and IL-2R in lung cancerP Marino, A Preatoni, L Fonticoli, et al.
The International Journal of Biological Markers|January 1, 1992
Tissue polypeptide specific antigen (TPS) and objective response to treatment in solid tumorsP Marino, G Buccheri, A Preatoni, et al.
British Journal of Cancer|March 1, 1990
Increased levels of soluble interleukin-2 receptors in serum of patients with lung cancerP Marino, M Cugno, A Preatoni, et al.
Pageof 2